We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3034:TWSENovatek Microelectronics Corp. Analysis

Data as of 2026-03-11 - not real-time

NT$388.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Novatek Microelectronics is trading just below its recent resistance of TWD 393 with the price at TWD 388.5, sitting above the 20‑day and 50‑day SMAs but well under the 200‑day SMA, indicating short‑term momentum in a longer‑term bearish backdrop. The MACD has turned bullish, the histogram is positive and the RSI sits in the mid‑50s, suggesting limited upside potential in the near term. Valuation metrics are compelling: the forward PE of roughly 13x is far below the semiconductor industry average of 37x, positioning the stock as a clear value play. However, the 30‑day volatility exceeds 26% and the beta of 0.73 points to price swings that can outpace the market, especially on earnings surprises.
The latest earnings call revealed a 10% YoY revenue decline, yet gross margins improved to about 38%, and the company continues to distribute a generous 7.3% dividend yield. The payout ratio hovers near 98%, raising questions about dividend sustainability if earnings pressure persists. A massive cash pile (over TWD 39 bn) and minimal debt provide a strong balance‑sheet cushion, while ROE is near 25%, underscoring efficient capital use. Overall, the stock offers attractive income and valuation but faces short‑term volatility and medium‑term growth headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near resistance with bullish MACD crossover
  • moderate RSI leaves limited upside
  • elevated short‑term volatility may trigger swings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount versus industry peers
  • strong cash position and low debt enhance financial stability
  • high dividend yield attractive for income‑focused investors

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • revenue contraction raises concerns about sustainable growth
  • dividend sustainability questionable given near‑100% payout ratio
  • robust ROE and ample cash provide a defensive buffer

Key Metrics & Analysis

Financial Health

Revenue Growth-9.70%
Profit Margin16.24%
P/E Ratio13.5
ROE24.86%
Debt/Equity0.88
P/B Ratio3.7
Industry P/E36.9

Technical Analysis

TrendBearish
RSI56.4
SupportNT$352.00
ResistanceNT$393.00
MA 20NT$377.05
MA 50NT$379.63
MA 200NT$432.66
MACDBullish
VolumeIncreasing
Fear & Greed Index76.52

Valuation

Target PriceNT$391.25
Upside/Downside0.71%
GradeUndervalued
TypeBlend
Dividend Yield7.28%

Risk Assessment

Beta0.73
Volatility26.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.